Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Measles and meningitis are resurging, showing the critical need to //strengthen immunization efforts worldwide * Low vaccine coverage is driving the return of diseases like yell ...

The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.